Agomelatine efficacy and acceptability revisited: systematic review and meta-analysis of published and unpublished randomised trials
about
Agomelatine versus other antidepressive agents for major depressionParent skills training for parents of children or adults with developmental disorders: systematic review and meta-analysis protocolComparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials.Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studiesEvaluation of the highly variable agomelatine pharmacokinetics in Chinese healthy subjects to support bioequivalence studyAgomelatine in the treatment of major depressive disorder: an assessment of benefits and risksAgomelatine beyond borders: current evidences of its efficacy in disorders other than major depressionNorth American regulatory agencies can and should make clinical trial data publicly available.Efficacy and tolerability of agomelatine in the treatment of depressionElectroretinographic modifications induced by agomelatine: a novel avenue to the understanding of the claimed antidepressant effect of the drug?Agomelatine - is it another reboxetine? Another case of publication biasComparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or agAgomelatine: an agent against anhedonia and abulia?Desvenlafaxine for the treatment of major depressive disorder.Issues encountered in recent attempts to develop novel antidepressant agents.Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines.Comparative efficacy, acceptability, and tolerability of dexmethylphenidate versus placebo in child and adolescent ADHD: a meta-analysis of randomized controlled trials.Vortioxetine for depression in adults.Melatonin as a treatment for mood disorders: a systematic review.The Psychiatric Inclusion and Exclusion Criteria in Placebo-Controlled Monotherapy Trials of Bipolar Depression: An Analysis of Studies of the Past 20 Years.Inclusion/exclusion criteria in late life depression antidepressant efficacy trials.Does melatonin treatment change emotional processing? Implications for understanding the antidepressant mechanism of agomelatine.Agomelatine or ramelteon as treatment adjuncts in glioblastoma and other M1- or M2-expressing cancers.Search for unpublished data by systematic reviewers: an audit.Effect of Agomelatine and Fluoxetine on HAM-D Score, Serum Brain-Derived Neurotrophic Factor, and Tumor Necrosis Factor-α Level in Patients With Major Depressive Disorder With Severe Depression.The impact of antidepressant treatments on family functioning in adults with major depressive disorder: a post hoc comparison of vortioxetine and agomelatine.Agomelatine: a new option for treatment of depression?Stability-Indicating HPLC and HPTLC Methods for Determination of Agomelatine and its Degradation Products.
P2860
Q24201746-80A54109-B347-42CF-9205-B3F30CE136B4Q24563614-6738884B-2F1C-491F-B90A-BDAC3AF83A69Q27692676-0B4ACE7B-CDFB-4771-BDA9-C95997267F69Q28236293-699FFE1B-631B-4C94-A79A-895CB64E51F2Q28543925-2A58BEB6-C1A8-448C-9A19-75E70C0C5ED9Q28651497-956E5841-412E-45A6-9935-37915E2C4B75Q28651498-9F84460E-D667-4A44-B8F9-D22E0D1F1693Q31004834-4A8BF5D4-1342-4990-ADE0-DB348075F160Q33583450-2F375779-632E-46C9-AD72-01964766ECDCQ33685314-015CB965-3B88-4657-96AE-C23BA0E2F71CQ33971236-E5A1B0E1-6661-4B9B-B975-558106D52C42Q34040072-F29CF7F2-E968-4A63-894A-AEE5814F9936Q34041642-FE28394A-04CB-4F32-B032-38CC47B33B23Q38169108-5444771A-57EB-4847-936C-59E2BD6BF2C0Q38219037-950CF913-17D2-42B7-BE8A-B37352ADB05EQ38374429-6619697C-38F3-45D3-A492-B6A64546D1B6Q38476909-358D5CD4-F361-4FC0-A5F2-389F5FC48AC5Q38663390-B84DA7A8-F15A-4797-A8F3-A390298BE00CQ38693309-BC22051D-7E5E-4712-BA3B-FAD87EF3333FQ38726221-C33EC5BC-839D-44AD-8DD3-A8F91286F2E4Q38931913-4CDA45BC-3D2C-4FDF-87C7-2C0DBF4DD60EQ38933448-90AB2D2E-C7D9-41BD-B2A0-B1BA1D77477CQ40737578-4E0996DE-BB67-4963-BA0C-7EF93A72CA22Q41103172-C8CA92BC-8820-49E4-89A9-9E87B7371F71Q42376820-D554BEE3-CCE2-4284-AA66-260C138F225EQ47790524-442D82B4-D1C9-42E5-9296-3ADAF18E7D0CQ47950300-70782826-B6C2-4185-BDA9-A2E40E91B676Q48375336-EF0732C8-F862-4B95-926E-3467B56BD0C8Q50001225-41C28130-D25B-4460-8F68-DAA7E74B4280
P2860
Agomelatine efficacy and acceptability revisited: systematic review and meta-analysis of published and unpublished randomised trials
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Agomelatine efficacy and accep ...... unpublished randomised trials
@ast
Agomelatine efficacy and accep ...... unpublished randomised trials
@en
Agomelatine efficacy and accep ...... unpublished randomised trials
@nl
type
label
Agomelatine efficacy and accep ...... unpublished randomised trials
@ast
Agomelatine efficacy and accep ...... unpublished randomised trials
@en
Agomelatine efficacy and accep ...... unpublished randomised trials
@nl
prefLabel
Agomelatine efficacy and accep ...... unpublished randomised trials
@ast
Agomelatine efficacy and accep ...... unpublished randomised trials
@en
Agomelatine efficacy and accep ...... unpublished randomised trials
@nl
P31
P50
P1476
Agomelatine efficacy and accep ...... unpublished randomised trials
@en
P2093
Giuseppe Guaiana
Thomas Becker
P304
P356
10.1192/BJP.BP.112.120196
P407
P577
2013-09-01T00:00:00Z